A case of recurrent IgG4-related disease successfully treated with belimumab after remission of systemic lupus erythematosus

MLA

Yu Katayama, et al. “A Case of Recurrent IgG4-Related Disease Successfully Treated with Belimumab after Remission of Systemic Lupus Erythematosus.” Rheumatology (Oxford, England), vol. 61, no. 10, Apr. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....36c8e77eac36715358c513315098d740&authtype=sso&custid=ns315887.

APA

Yu Katayama, Takayuki Katsuyama, Kenta Shidahara, Shoichi Nawachi, Yosuke Asano, Keiji Ohashi, Yoshia Miyawaki, Eri Katsuyama, Mariko Narazaki, Yoshinori Matsumoto, Ken-Ei Sada, & Jun Wada. (2022). A case of recurrent IgG4-related disease successfully treated with belimumab after remission of systemic lupus erythematosus. Rheumatology (Oxford, England), 61(10).

Chicago

Yu Katayama, Takayuki Katsuyama, Kenta Shidahara, Shoichi Nawachi, Yosuke Asano, Keiji Ohashi, Yoshia Miyawaki, et al. 2022. “A Case of Recurrent IgG4-Related Disease Successfully Treated with Belimumab after Remission of Systemic Lupus Erythematosus.” Rheumatology (Oxford, England) 61 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....36c8e77eac36715358c513315098d740&authtype=sso&custid=ns315887.